Clinical trial

Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic…

NCT00054171 · Roswell Park Cancer Institute, Other · Completed

Key facts

NCT number NCT00054171
Title Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
Official title A Pilot Study of Short (1-2.5 h), Medium (4-6 h) and Long (18-24 h) Applications of 20% Topical ALA-PDT for Photodynamic Therapy of Cutaneous T and B Cell Lymphomas and Cutaneous Infiltrates of Early CLL
Lead sponsor Roswell Park Cancer Institute, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Leukemia, Lymphoma
Intervention type Drug
Interventions aminolevulinic acid hydrochloride
Enrollment 1
Start date Feb 1, 1999
Primary completion Jul 1, 2005
First posted Feb 6, 2003
Last update posted Jan 31, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies